ArticleCureus2025
Prevalence and Predictors of Urinary Tract Infections Among Patients With Type 2 Diabetes Attending Primary Health Care Centers in Buraidah City, Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrinary tract infections (UTIs) are a common occurrence among patients with diabetes mellitus (DM); it also depends on the duration and associated comorbidities. Frequent urinary tract infections (UTIs) can lead to long-term complications such as glomerulonephritis and prostatitis, and in some cases, bacteria may spread through the bloodstream, leading to sepsis. The objective of the study is to assess the prevalence and predictors of UTI among patients with type 2 DM (T2DM).
methodsA cross-sectional study was conducted among 400 primary health care centers (PHCCs) with attendees who had T2DM. A semi-structured, self-administered questionnaire was created on Google Forms (Google Inc., Mountain View, CA) to be shared with PHCC attendees by the principal investigator through WhatsApp (Meta Platforms, Inc., Menlo Park, CA). About 72.5% (n=290) responded in our study. A convenience sampling method was used to select participants based on criteria. Data were transferred, cleaned, and analyzed with IBM SPSS Statistics software, version 21.0 (IBM Corp., Armonk, NY). Logistic regression analysis was applied to identify the predictors of UTI among patients with T2DM and their associated risk factors.
resultsThis study found a significant prevalence of UTIs among patients with T2DM, with 67.9% (n=197) reporting at least one episode within 12 months. The mean age and standard deviation in the study population were 58.15 ± 12.71, with females being 54.5% (n=158). Frequent micturition (70%, n=203) and burning micturition (64.1%, n=186) were identified as major symptoms. Key risk factors included cervicitis and Foley catheter use, with notable odds ratios (OR): 3.55, CI: 1.266 to 9.959, P=0.016; OR: 2.29, CI: 0.858 to 6.160, P=0.098, respectively. Demographic factors such as age, education, and income showed no significant difference in UTI risk. The antibiotic adherence in the study group was 62.4% (n=181).
conclusionsNearly two-thirds (67.9%, n=197) had UTIs among patients with T2DM, with frequent and burning micturition as key symptoms. The predictors of UTI among patients with T2DM were major risk factors of cervicitis and Foley catheter use, while education and income showed no impact. The study highlights the need for early diagnosis of UTI, improved antibiotic adherence, and management strategies, including glycemic control, to reduce UTI risks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.